All Industries

Top Life Sciences Companies

372 Life Sciences companies, sorted by total funding raised.

Capital Rx

Full-service pharmacy benefits manager and administrator serving employers and health plans with ...

New York City, United States501–1000Life Sciences, Healthcare
Series F·$452.3M·Sep 2025
GalectoIPO

Clinical-stage biotech developing small-molecule therapeutics targeting galectin and other mechan...

Copenhagen, Denmark11–50Biotech, Drug Development
Series C·$446.9M·Nov 2025
Areteia TherapeuticsClosed

Clinical-stage biotechnology developing an oral eosinophil-maturation inhibitor (dexpramipexole) ...

Chapel Hill, United States11–50Biotech, Life Sciences
Series A·$425.0M·Feb 2024
Transcarent

Transcarent is the One Place for Health and Care that makes it easy for people to access high-qua...

San Francisco, United StatesLife Sciences, Artificial Intelligence
Series D·$424.0M·May 2024
Verdiva Bio

Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative therap...

London, United Kingdom11–50Life Sciences, Biotech
Series A·$411.0M·Jan 2025
Sonoma Biotherapeutics

Develops engineered regulatory T cell therapies to restore immune balance and treat autoimmune an...

Seattle, United States51–200Biotech, Life Sciences
Corporate Round·$410.0M·Sep 2024
Color

Population-scale health company delivering genetic testing, cancer screening, and virtual clinica...

Burlingame, United States501–1000Life Sciences, Biotech
Series E·$402.0M·Nov 2021
apprentice.io

Apprentice.io is an intelligent software company that builds solutions for global life science te...

Jersey City, United States51–200Life Sciences, Manufacturing Software
Series E·$397.0M·Jan 2025
Avalyn

Developing inhaled therapies to treat people with severe respiratory disease.

Boston, United States11–50Biotech, Healthcare
Series D·$372.5M·Jul 2025
Umoja

Develops in vivo CAR T cell therapies that generate CAR T cells inside patients to treat cancer.

Seattle, United States201–500Biotech, Drug Discovery
Series C·$363.0M·Jan 2025
Ro

Direct-to-patient telehealth company offering prescription treatments for weight loss, sexual hea...

New York, United States501–1000Life Sciences, Healthcare
Series D·$350.0M·Feb 2022
Dewpoint Therapeutics

Biotech company applying biomolecular condensate science to drug discovery across oncology, neuro...

Boston, United States51–200Life Sciences, Biotech
Series D·$346.1M·Sep 2025
Redesign Health

Venture and applied-technology firm that builds and funds healthcare startups, partnering with fo...

New York, United States51–200Life Sciences, Artificial Intelligence
Venture Unknown·$340.0M·Dec 2024
nChroma Bio

Genetic medicines company developing targeted in vivo delivery and engineered epigenetic silencer...

Boston, United States51–200Biotech, Genomics
Corporate Round·$335.0M·Dec 2024
MEGAROBO

AI-powered robotics platform for laboratory automation, life sciences, and smart manufacturing in...

Beijing, China201–500Robotics, Life Sciences
Series C·$330.0M·Jun 2022
Solve Therapeutics

Solve Therapeutics is a biopharmaceutical company that develops next-gen antibody-drug conjugates...

Belmont, United States11–50Life Sciences, Biotech
Series B·$321.0M·Nov 2025
Zenas BioPharmaIPO

Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the devel...

Boston, United States51–200Biotech, Healthcare
Series C·$318.0M·May 2024
ArriVentIPO

Clinical-stage biopharma developing and commercializing oncology therapeutics, partnering to glob...

Newtown Square, United States11–50Life Sciences, Biotech
Series B·$305.0M·Mar 2023
Arbor Biotechnologies

Develops next-generation gene editing therapeutics for genetic diseases, advancing liver and CNS ...

Cambridge, United States51–200Biotech, Drug Discovery
Series C·$304.5M·Mar 2025
Valo Health

AI-enabled biotechnology company using large-scale human data and computation to accelerate drug ...

Boston, United States51–200Artificial Intelligence, Biotech
Series B·$300.0M·Mar 2021
LifeMine Therapeutics

Clinical-stage biopharma mining fungal genomes to discover genetically-encoded small molecules fo...

Cambridge, United States51–200Biotech, Drug Discovery
Venture Unknown·$300.0M·Jan 2025
Kronos BioClosed

Clinical-stage biopharma developing small‑molecule therapeutics targeting deregulated transcripti...

San Mateo, United States1–10Biotech, Healthcare
Series B·$260.0M·Aug 2020
Frontier Medicines

Clinical-stage precision-medicine biotech using chemoproteomics and AI to discover covalent small...

San Francisco, United States51–200Biotech, Drug Discovery
Extension Round·$255.5M·Jun 2024
SonderMind

Technology-driven behavioral health platform connecting individuals with therapists and mental he...

Denver, United States201–500Healthcare, Life Sciences
Venture Unknown·$255.0M·Jan 2025
PathAI

PathAI is a leading provider of AI-powered research tools and services for pathology.

Boston, United States201–500Artificial Intelligence, Biotech
Series C·$251.0M·May 2021